Factory Supply Bulk Price 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetic Acid 2026
- Direct Manufacturing: Eliminate distributor markups by sourcing CAS 17745-04-9 directly from the production site.
- Technical Specifications: Guaranteed industrial purity exceeding 98% with full COA and HPLC validation.
- 2026 Pricing Trends: Locked-in bulk price contracts available for long-term pharmaceutical supply agreements.
The pharmaceutical landscape in 2026 demands rigorous supply chain transparency and technical excellence, particularly for heterocyclic building blocks used in kinase inhibitor development. 2-(Imidazo[1,2-a]pyridin-3-yl)acetic Acid (CAS: 17745-04-9) serves as a critical chemical building block for the synthesis of minodronic acid derivatives and other bioactive agents. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. provides comprehensive data on synthesis scalability, purification protocols, and cost-effective procurement strategies for this high-value intermediate.
Procurement managers and process chemists must evaluate not only the headline cost but the total cost of ownership, which includes purity profiles, logistical reliability, and technical support. Small-scale catalog pricing often obscures the significant economic advantages available through direct factory supply channels. This analysis details the technical parameters and commercial structures required for successful bulk integration of this imidazopyridine derivative into your production workflow.
Technical Synthesis and Industrial Purity Profiles
Understanding the synthesis route is essential for qualifying a supplier for GMP-grade production. The manufacturing process for CAS 17745-04-9 typically involves the condensation of 2-aminopyridine with appropriate keto-esters, followed by hydrolysis and purification. Achieving consistent industrial purity requires stringent control over reaction parameters, including temperature ramping, solvent selection, and crystallization kinetics.
Our production facilities utilize continuous flow chemistry enhancements to improve reaction yields and reduce impurity profiles such as residual starting materials or isomeric byproducts. Each batch undergoes rigorous quality control testing using High-Performance Liquid Chromatography (HPLC) and Nuclear Magnetic Resonance (NMR) spectroscopy. Clients receive a comprehensive Certificate of Analysis (COA) detailing assay content, residual solvents, and heavy metal compliance. When sourcing high-purity 2-(Imidazo[1,2-a]pyridin-3-yl)acetic Acid, buyers should prioritize suppliers who can demonstrate batch-to-batch consistency through documented process validation.
Quality Control Parameters
To ensure suitability for downstream pharmaceutical applications, the following technical specifications are maintained across all bulk production runs:
- Assay: NLT 98.0% (HPLC Area %)
- Appearance: Off-white to light yellow crystalline powder
- Water Content: NMT 0.5% (Karl Fischer)
- Residual Solvents: Compliant with ICH Q3C Guidelines
- Heavy Metals: NMT 10 ppm
Factory Direct Pricing Models and Volume Tiers
Market analysis indicates a significant disparity between research-grade pricing and industrial bulk price structures. While small quantities (milligram to gram scale) may command prices exceeding $1,000 per gram due to packaging and handling overheads, kilogram and ton-scale procurement offers substantial cost reductions. NINGBO INNO PHARMCHEM CO.,LTD. operates on a transparent pricing model that reflects raw material costs, energy consumption, and purification complexity without intermediary margins.
Volume tier discounts are structured to reward long-term commitment and larger order quantities. This approach allows pharmaceutical companies to optimize their COGS (Cost of Goods Sold) for final drug products. The table below outlines the estimated pricing tiers for 2026, reflecting the economic benefits of scaling procurement.
| Quantity Tier | Packaging | Lead Time | Price Indicator |
|---|---|---|---|
| 100g - 1kg | Double PE Bag + Foil | 1-2 Weeks | Premium Research Rate |
| 1kg - 10kg | Drum / Carton | 2-3 Weeks | Standard Bulk Rate |
| 10kg - 100kg | Fiber Drum | 3-4 Weeks | Discounted Volume Rate |
| 100kg+ | Custom Bulk | 4-6 Weeks | Contract Manufacturing Rate |
It is critical to note that these prices exclude delivery fees, bank fees, or handling fees, which vary based on destination and incoterms (FOB, CIF, DDP). Custom synthesis options are available for clients requiring specific particle size distributions or salt forms, such as the hydrochloride salt, which may alter the molecular weight and pricing structure.
2026 Market Forecast and Supply Chain Stability
The demand for imidazopyridine derivatives is projected to grow steadily through 2026, driven by increased R&D activity in oncology and metabolic disease therapeutics. Supply chain resilience remains a top priority for procurement officers. Reliance on single-source distributors introduces risk; therefore, establishing a direct relationship with a reliable supplier capable of scaling production is essential.
Raw material availability for the precursors of CAS 17745-04-9 remains stable, but geopolitical factors can influence logistics costs. Forward contracting is recommended to lock in current bulk price levels before anticipated market adjustments. Our facility maintains strategic stockpiles of key starting materials to mitigate supply shocks and ensure uninterrupted delivery schedules for our partners.
Strategic Procurement Recommendations
To maximize value and minimize risk in the 2026 fiscal year, buyers should consider the following strategies:
- Audit Supplier Capabilities: Verify manufacturing licenses and quality management systems before signing contracts.
- Request Samples: Conduct internal testing on pre-production samples to validate compatibility with your synthesis workflow.
- Negotiate Terms: Leverage volume commitments to secure favorable payment terms and priority production slots.
In conclusion, securing a stable supply of 2-(Imidazo[1,2-a]pyridin-3-yl)acetic Acid requires a partner who understands both the chemical nuances and the commercial realities of the pharmaceutical industry. By choosing NINGBO INNO PHARMCHEM CO.,LTD., organizations gain access to superior technical support, verified pharma grade materials, and competitive pricing structures designed for scale. Contact our sales team today to request a quote and initiate the qualification process for your upcoming projects.